Ani’s rise showed how chatbots became partners instead of tools, driving a year of AI intimacy and its human consequences.

One week after King Charles III initiated the formal process to remove the style, titles and honors of Prince Andrew, his brother's name was notably missing from the royal website. Buckingham Palace ...

The U.S. FDA has granted orphan drug designation to Dewpoint Therapeutics Inc.’s DPTX-3186, its first-in-class condensate modulator for the treatment of gastric cancer. The designation follows the ...

Your Discord bio is a quick way for others to learn about you, and for you to introduce yourself, your likes, and interests with others. But it’s not easy to come up with something that accurately ...

Trualt Bioenergy IPO: The initial public offer (IPO) of leading ethanol producer Trualt Bioenergy opened on September 25 and will close for subscription today, September 29. The ₹839.28 crore IPO, had ...

SAN DIEGO--(BUSINESS WIRE)--Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced today that the U.S. Food and Drug Administration (FDA) has issued a “no ...

Clear, detailed sound that rivals the best on the market. Comfy and unique design. Superb noise canceling. Not great for calls in loud environments. Never heard of Status Audio? I don’t blame you. The ...

2K has confirmed the troubled state of their long-in-development BioShock project at their internal studio Cloud Chamber. Unfortunately, there were layoffs as the project refocuses. But the good news ...

The U.S. Food & Drug Administration has granted orphan drug designation to Chicago-based Amphix Bio's treatment for acute spinal cord injury, or SCI. Its makers hope the drug could someday let people ...

Basic security flaws left the personal info of tens of millions of McDonald’s job-seekers vulnerable on the “McHire” site built by AI software firm Paradox.ai. Until last week, the platform that runs ...

Shares of Mustang Bio (NASDAQ:MBIO) jumped on Monday after the company said that the U.S. FDA has granted orphan drug status to its CAR T-cell therapy, MB-101, for the treatment of astrocytoma and ...

LEXINGTON, Mass.--(BUSINESS WIRE)--#CancerCare--Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab (BOT/BAL) combination achieved ...